Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Liraglutide by Novo Nordisk for Obesity: Likelihood of Approval
Liraglutide is under clinical development by Novo Nordisk and currently in Phase III for Obesity. According to GlobalData, Phase III...
Data Insights
Liraglutide by Novo Nordisk for Alzheimer's Disease: Likelihood of Approval
Liraglutide is under clinical development by Novo Nordisk and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...